FDA clears Bacchus' thrombectomy catheter:
This article was originally published in Clinica
Executive Summary
Bacchus Vascular (Santa Clara, California) has received US FDA 510(k) marketing clearance for its minimally invasive Solera thrombectomy catheter for removing blood clots in patients with haemodialysis access grafts. The product, which was also recently cleared for sale in Europe, is a battery-operated, handheld device that macerates blood clots in a rapid and effective manner.